alendronate has been researched along with Hypertension in 7 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The arterial hypertension is a disorder characterized by relevant alterations in the bone tissue." | 1.35 | Local action of sodium alendronate in bone repair of spontaneously hypertensive rat (SHR). ( Chin, CM; Faig-Leite, H; Fernandes, RG; Nobre, MD, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Fede, O | 1 |
| Fusco, V | 1 |
| Matranga, D | 1 |
| Solazzo, L | 1 |
| Gabriele, M | 1 |
| Gaeta, GM | 1 |
| Favia, G | 1 |
| Sprini, D | 1 |
| Peluso, F | 1 |
| Colella, G | 1 |
| Vescovi, P | 1 |
| Campisi, G | 1 |
| López-Cedrún, JL | 1 |
| Sanromán, JF | 1 |
| García, A | 1 |
| Peñarrocha, M | 1 |
| Feijoo, JF | 1 |
| Limeres, J | 1 |
| Diz, P | 1 |
| Casiano, V | 1 |
| Kalish, VB | 1 |
| Unwin, B | 1 |
| Nobre, MD | 1 |
| Fernandes, RG | 1 |
| Chin, CM | 1 |
| Faig-Leite, H | 1 |
| Li, L | 2 |
| Chen, GP | 2 |
| Yang, Y | 2 |
| Ye, Y | 1 |
| Yao, L | 2 |
| Hu, SJ | 2 |
| Fu, M | 1 |
| Wu, T | 1 |
| Zhang, XQ | 1 |
| Zethraeus, N | 1 |
| Ström, O | 1 |
| Borgström, F | 1 |
| Kanis, JA | 1 |
| Jönsson, B | 1 |
7 other studies available for alendronate and Hypertension
| Article | Year |
|---|---|
Osteonecrosis of the jaws in patients assuming oral bisphosphonates for osteoporosis: a retrospective multi-hospital-based study of 87 Italian cases.
Topics: Administration, Oral; Adrenal Cortex Hormones; Age Factors; Aged; Aged, 80 and over; Alendronate; Bi | 2013 |
Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Alendronate; Bisphosphonate-Associated Osteonec | 2013 |
An unusual adverse event from a common medication in an individual with dementia.
Topics: Administration, Oral; Aged, 80 and over; Alendronate; Alzheimer Disease; Deglutition Disorders; Fema | 2014 |
Local action of sodium alendronate in bone repair of spontaneously hypertensive rat (SHR).
Topics: Alendronate; Analysis of Variance; Animals; Bone Density Conservation Agents; Bone Regeneration; Dis | 2008 |
Chronic inhibition of farnesyl pyrophosphate synthase attenuates cardiac hypertrophy and fibrosis in spontaneously hypertensive rats.
Topics: Alendronate; Animals; Cardiomegaly; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibrosis; G | 2010 |
Chronic inhibition of farnesyl pyrophosphate synthase improves endothelial function in spontaneously hypertensive rats.
Topics: Alendronate; Animals; Aorta, Thoracic; Dimethylallyltranstransferase; Endothelium, Vascular; Enzyme | 2010 |
The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden.
Topics: Aged; Aged, 80 and over; Alendronate; Antihypertensive Agents; Bone Density Conservation Agents; Cos | 2008 |